More data back Guillain-Barré risk with Janssen COVID shotFebruary 3, 2023COVID-19 UpdatesNeurologyVaccinesPreventive CareImmunologyRare Diseases
VEXAS syndrome: More common, variable, and severe than expectedJanuary 24, 2023Rare DiseasesHematologyRheumatologyAnemia
Cancer clinics begin to accommodate patients demanding new cancer detection testsJanuary 9, 2023Preventive CareBreast CancerRare DiseasesMixed TopicsOncology
Doctors urge screening for autoimmune disorders for patients with celiac diseaseNovember 16, 2022GastroenterologyImmunologyPreventive CareRare DiseasesMixed Topics
Combination therapy shows mixed results for scleroderma-related lung diseaseNovember 15, 2022PulmonologyRare DiseasesRheumatologyDermatology
Clinical signs differ between children and adults with vasculitisNovember 13, 2022Rare DiseasesRheumatology
First recommendations for cancer screening in myositis issuedNovember 12, 2022RheumatologyOncologyRare DiseasesPreventive Care
Gene ‘cut-and-paste’ treatment could offer hope for inherited immune system diseasesOctober 27, 2022Rare DiseasesMixed TopicsRheumatologyImmunology
Goodbye ‘diabetes insipidus’, hello ‘AVP-D’ and ‘AVP-R’October 25, 2022DiabetesRare DiseasesNephrologyEndocrinology
The broad and challenging – but promising – landscape of peripheral neuropathyOctober 15, 2022Rare DiseasesNeurology
NORD Rare Disease Centers of Excellence: A new network seeks to break down barriers in rare disease careOctober 15, 2022Rare Diseases
